Follitropin alfa biosimilar - Dong-A ST/Genexine

Drug Profile

Follitropin alfa biosimilar - Dong-A ST/Genexine

Alternative Names: DA-3801; Gonadopin; Gonadorphin; GX-F11

Latest Information Update: 15 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dong-A Pharmaceutical
  • Developer Dong-A ST
  • Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins; Recombinant proteins
  • Mechanism of Action Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Female infertility

Highest Development Phases

  • Marketed Female infertility; Infertility

Most Recent Events

  • 18 Mar 2016 Launched for Ovulation induction in anovulatory women in South Korea (Parenteral) (Dong-A ST Annual Report 2015)
  • 08 May 2015 Preregistration for Infertility in South Korea (Parenteral)
  • 08 May 2015 Dong-A files NDA for Infertility (Anovulation) in South Korea
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top